Comment on “Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19”
Author:
- 2 June 2020
- journal article
- letter
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (9) , 1425-1426
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19Circulation Research, 2020
- Comment on “Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19”Journal of Medical Virology, 2020
- Endothelial cell infection and endotheliitis in COVID-19The Lancet, 2020
- CD‐sACE2 inclusion compounds: An effective treatment for coronavirus disease 2019 (COVID‐19)Journal of Medical Virology, 2020
- Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19Journal of Medical Virology, 2020
- Amiloride Improves Endothelial Function and Reduces Vascular Stiffness in Female Mice Fed a Western DietFrontiers in Physiology, 2017
- ACE2 and Ang-(1–7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory responseInflammation Research, 2015
- Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonistsJournal of Human Hypertension, 2002